QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.059600v1 308/3/1053    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Donnelly-Roberts, D. L. Articles by Jarvis, M. F. Search for Related Content PubMed PubMed Citation Articles by Donnelly-Roberts, D. L. Articles by Jarvis, M. F.

CELLULAR AND MOLECULAR

Mitogen-Activated Protein Kinase and Caspase Signaling Pathways Are Required for P2X₇ Receptor (P2X₇R)-Induced Pore Formation in Human THP-1 Cells

Neuroscience Research, Global Pharmaceutical Research and Development Abbott Laboratories, Abbott Park, Illinois

Brief activation of the ATP-sensitive P2X₇ receptor (P2X₇R) stimulates the maturation and release of interleukin 1 (IL-1)in macrophages, whereas prolonged agonist activation induces the formation of cytolytic pores in cell membranes. The present study investigated potential downstream mechanisms associated with native human P2X₇R activation in lipopolysaccharide and interferon- differentiated THP-1 cells. 2,3-O-(4-Benzoylbenzoyl)-ATP (BzATP)-induced pore formation (EC₅₀ = 35 µM) was blocked by a selective P2X₇R antagonist, 1[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine (KN-62) (IC₅₀ = 44 nM) and by pyridoxal phosphate-6-azophenyl-2-4-disulfonic acid (PPADS) (IC₅₀ = 344 nM). KN-62 and PPADS also blocked BzATP-induced IL-1 release (EC₅₀ = 617 µM) with IC₅₀ values of 75 and 3500 nM, respectively. The selective p38 mitogen-activated protein kinase (MAPK) inhibitor, 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole (SB 202190), potently inhibited BzATP-induced pore formation (IC₅₀ = 75 nM) but did not alter P2X₇-mediated calcium influx or IL-1 release. SB 202190 and KN-62 also attenuated BzATP-mediated activation of phosphorylated p38 MAPK (pp38 MAPK). Two caspase inhibitors, YVAD (caspase 1) and DEVD (caspase 3), attenuated both BzATP-induced pore formation and IL-1 release in a concentration-dependent fashion. Neither DEVD nor p38-MAPK inhibitors blocked cell membrane pore formation evoked by maitotoxin or by activation of human P2X_2a receptors. These results indicate that P2X₇R-mediated pore formation results from a coordinated cascade involving both the p38 MAPK and caspase pathways that is distinct from other cytolytic pore-forming mechanisms. In contrast, P2X₇R-mediated IL-1 release is dependent on caspase activity but not p38 MAPK. Taken together, these results support the hypothesis that downstream cellular signaling mechanisms, rather than channel dilation, mediate cytolytic pore formation after prolonged agonist activation, which underlies P2X₇ receptors.

Address correspondence to: Diana L. Donnelly-Roberts, Abbott Laboratories, 100 Abbott Park Rd., Bldg. AP9A, Dept. R4PM, Abbott Park, IL 60064-6123. E-mail: diana.l.donnelly-roberts{at}abbott.com

This article has been cited by other articles:

				T. Noguchi, K. Ishii, H. Fukutomi, I. Naguro, A. Matsuzawa, K. Takeda, and H. Ichijo Requirement of Reactive Oxygen Species-dependent Activation of ASK1-p38 MAPK Pathway for Extracellular ATP-induced Apoptosis in Macrophage J. Biol. Chem., March 21, 2008; 283(12): 7657 - 7665. [Abstract] [Full Text] [PDF]

				C. Guo, M. Masin, O. S. Qureshi, and R. D. Murrell-Lagnado Evidence for Functional P2X4/P2X7 Heteromeric Receptors Mol. Pharmacol., December 1, 2007; 72(6): 1447 - 1456. [Abstract] [Full Text] [PDF]

				P. Honore, D. Donnelly-Roberts, M. T. Namovic, G. Hsieh, C. Z. Zhu, J. P. Mikusa, G. Hernandez, C. Zhong, D. M. Gauvin, P. Chandran, et al. A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1376 - 1385. [Abstract] [Full Text] [PDF]

				L.-H. Jiang, F. Rassendren, A. Mackenzie, Y.-H. Zhang, A. Surprenant, and R. A. North N-methyl-D-glucamine and propidium dyes utilize different permeation pathways at rat P2X7 receptors Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1295 - C1302. [Abstract] [Full Text] [PDF]

				R. Auger, I. Motta, K. Benihoud, D. M. Ojcius, and J. M. Kanellopoulos A Role for Mitogen-activated Protein KinaseErk1/2 Activation and Non-selective Pore Formation in P2X7 Receptor-mediated Thymocyte Death J. Biol. Chem., July 29, 2005; 280(30): 28142 - 28151. [Abstract] [Full Text] [PDF]

				L. Liang and E. M. Schwiebert Large pore formation uniquely associated with P2X7 purinergic receptor channels. Focus on "Are second messengers crucial for opening the pore associated with P2X7 receptor?" Am J Physiol Cell Physiol, February 1, 2005; 288(2): C240 - C242. [Full Text] [PDF]

				R. X. Faria, F. P. DeFarias, and L. A. Alves Are second messengers crucial for opening the pore associated with P2X7 receptor? Am J Physiol Cell Physiol, February 1, 2005; 288(2): C260 - C271. [Abstract] [Full Text] [PDF]